Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice

Experimental Neurology

Volumn 222, Issue 2, 2010, Pages 235-242

  Gomez Nicola, Diego ^a,b   Spagnolo, Alessandra ^a   Guaza, Carmen ^a   Nieto Sampedro, Manuel ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

CD4; CD8; CX3CR1; Cytokines; Demyelination; Multiple sclerosis

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; INTERLEUKIN 15;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPINAL CORD; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CYTOKINES; DEMYELINATING DISEASES; ELIMINATIVE BEHAVIOR, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOPROTEINS; INTERLEUKIN-15; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN BASIC PROTEINS; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; RECEPTORS, CHEMOKINE; SPINAL CORD;

EID: 77549084952     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.12.034     Document Type: Article

References (48)

1. Afzali B., Lombardi G., Lechler R.I., and Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148 (2007) 32-46
2. Anderton S.M., and Liblau R.S. Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 21 (2008) 248-254
3. Armitage R.J., Macduff B.M., Eisenman J., Paxton R., and Grabstein K.H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154 (1995) 483-490
4. Barlic J., Sechler J.M., and Murphy P.M. IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 102 (2003) 3494-3503
5. Barlic J., Sechler J.M., and Murphy P.M. IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 102 (2003) 3494-3503
6. Barlic J., McDermott D.H., Merrell M.N., Gonzales J., Via L.E., and Murphy P.M. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective N. J. Biol. Chem. 279 (2004) 48520-48534
7. Barlic J., McDermott D.H., Merrell M.N., Gonzales J., Via L.E., and Murphy P.M. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective N. J. Biol. Chem. 279 (2004) 48520-48534
8. Berard M., Brandt K., Bulfone-Paus S., and Tough D.F. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J. Immunol. 170 (2003) 5018-5026
9. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
10. Budagian V., Bulanova E., Paus R., and Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17 (2006) 259-280
11. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Ruckert R., Krause H., and Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3 (1997) 1124-1128
12. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., and Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006) 917-924
13. Fehniger T.A., and Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 97 (2001) 14-32
14. Friese M.A., and Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?. Brain 128 (2005) 1747-1763
15. Gomez-Nicola D., Doncel-Perez E., and Nieto-Sampedro M. Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15. J. Neurosci. Res. 83 (2006) 754-762
16. Gomez-Nicola D., Valle-Argos B., Pita-Thomas D.W., and Nieto-Sampedro M. Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia 56 (2008) 494-505
17. Gomez-Nicola D., Valle-Argos B., Suardiaz M., Taylor J.S., and Nieto-Sampedro M. Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J. Neurochem. 107 (2008) 1741-1752
18. Gomez-Nicola, D., Valle-Argos, B., Nieto-Sampedro, M., 2009. Blockade of IL-15 activity inhibits microglial activation through the NFkB, p38 and ERK1/2 pathways, reducing cytokine and chemokine release. Glia. 58, 264-276.
19. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., and Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 (1994) 965-968
20. Hanisch U.K., Lyons S.A., Prinz M., Nolte C., Weber J.R., Kettenmann H., and Kirchhoff F. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J. Biol. Chem. 272 (1997) 28853-28860
21. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., and Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10896-10901
22. Howe C.L., Ure D., Adelson J.D., LaFrance-Corey R., Johnson A., and Rodriguez M. CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination. J. Neuroimmunol. 188 (2007) 13-21
23. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., Littman D.R., and Ransohoff R.M. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20 (2006) 896-905
24. Huang Z., Ha G.K., and Petitto J.M. IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy. Neurosci. Lett. 417 (2007) 160-164
25. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., Brasel K., Morrissey P.J., Stocking K., Schuh J.C., Joyce S., and Peschon J.J. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191 (2000) 771-780
26. Kivisakk P., Matusevicius D., He B., Soderstrom M., Fredrikson S., and Link H. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 111 (1998) 193-197
27. Kleinschnitz C., Hofstetter H.H., Meuth S.G., Braeuninger S., Sommer C., and Stoll G. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp. Neurol. 200 (2006) 480-485
28. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., and Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 566-573
29. Lee Y.B., Satoh J., Walker D.G., and Kim S.U. Interleukin-15 gene expression in human astrocytes and microglia in culture. NeuroReport 7 (1996) 1062-1066
30. Li X.C., Demirci G., Ferrari-Lacraz S., Groves C., Coyle A., Malek T.R., and Strom T.B. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat. Med. 7 (2001) 114-118
31. Losy J., Niezgoda A., and Zaremba J. IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol. 40 (2002) 151-153
32. Masuda A., Matsuguchi T., Yamaki K., Hayakawa T., and Yoshikai Y. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J. Biol. Chem. 276 (2001) 26107-26113
33. Montero E., Nussbaum G., Kaye J.F., Perez R., Lage A., Ben-Nun A., and Cohen I.R. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 23 (2004) 1-7
34. Nishimura M., Umehara H., Nakayama T., Yoneda O., Hieshima K., Kakizaki M., Dohmae N., Yoshie O., and Imai T. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168 (2002) 6173-6180
35. Peterson J.W., and Trapp B.D. Neuropathobiology of multiple sclerosis. Neurol. Clin. 23 (2005) 107-vii
36. Rasband, W.S., 2008 ImageJ 1.38x. 2008. 1997-2008, ImageJ,U.S.National Institutes of Health,Bethesda,Maryland,USA, http://rsb.info.nih.gov/ij/,1997-2007. Ref Type: Computer Program.
37. Rentzos M., Cambouri C., Rombos A., Nikolaou C., Anagnostouli M., Tsoutsou A., Dimitrakopoulos A., Triantafyllou N., and Vassilopoulos D. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 241 (2006) 25-29
38. Satoh J., Kurohara K., Yukitake M., and Kuroda Y. Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J. Neurol. Sci. 155 (1998) 170-177
39. Schluns K.S., Williams K., Ma A., Zheng X.X., and Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168 (2002) 4827-4831
40. Soriano S.G., Amaravadi L.S., Wang Y.F., Zhou H., Yu G.X., Tonra J.R., Fairchild-Huntress V., Fang Q., Dunmore J.H., Huszar D., and Pan Y. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125 (2002) 59-65
41. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85 (1996) 299-302
42. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 (2006) 12-21
43. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., and Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587
44. Sunnemark D., Eltayeb S., Nilsson M., Wallstrom E., Lassmann H., Olsson T., Berg A.L., and Ericsson-Dahlstrand A. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflammation 2 (2005) 17
45. Vaknin-Dembinsky A., Brass S., Gandhi R., and Weiner H.L. Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. J. Neuroimmunol. 195 (2008) 135-139
46. Waldmann T.A. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res. Ther. 6 (2004) 174-177
47. Zhang J., Weiner H.L., and Hafler D.A. Autoreactive T cells in multiple sclerosis. Int. Rev. Immunol. 9 (1992) 183-201
48. Zhang X., Sun S., Hwang I., Tough D.F., and Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8 (1998) 591-599